| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 102225 | Null | 0.0478540623811426 | 0.19380785 |
| NSC 107043 | Null | 0.0478540623811426 | 0.35181911 |
| NSC 128635 | Null | 0.0478540623811426 | 0.34760761 |
| NSC 132277 | Ethanesulfonic acid, compd. with 1,6-dihydro-6,6-dimethyl-1-[4-(4-phenylbutyl)phenyl]-1,3,5-triazine-2,4-diamine (1:1) | 0.0478540623811426 | 0.4617725 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0478540623811426 | 0.5082753 |
| NSC 134459 | Acetamide, N-(2-mercaptoethyl)-, benzoate (6CI, 7CI) | 0.0478540623811426 | 0.082163219 |
| NSC 164970 | Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- | 0.0478540623811426 | 0.087083064 |
| NSC 168516 | Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- | 0.0478540623811426 | 0.37633203 |
| NSC 292816 | 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) | 0.0478540623811426 | 0.14234303 |
| NSC 295499 | Camptothecin Derivative | 0.0478540623811426 | 0.28585783 |